Piramal Enterprises Limited (PEL.NS)
INR 1115.7
(-2.78%)
INR 1115.7
(-2.78%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 535.85 Billion INR | 8.23% |
| 2022 | 495.1 Billion INR | -11.12% |
| 2021 | 557.02 Billion INR | 40.82% |
| 2020 | 395.57 Billion INR | -6.35% |
| 2019 | 422.38 Billion INR | -24.61% |
| 2018 | 560.28 Billion INR | 26.86% |
| 2017 | 441.67 Billion INR | 45.01% |
| 2016 | 304.58 Billion INR | 87.38% |
| 2015 | 162.54 Billion INR | 122.48% |
| 2014 | 73.06 Billion INR | -23.51% |
| 2013 | 95.51 Billion INR | 24.24% |
| 2012 | 76.88 Billion INR | 362.4% |
| 2011 | 16.62 Billion INR | 119.68% |
| 2010 | 7.56 Billion INR | -41.55% |
| 2009 | 12.94 Billion INR | -3.29% |
| 2008 | 13.39 Billion INR | 86.94% |
| 2007 | 7.16 Billion INR | 12.06% |
| 2006 | 6.39 Billion INR | 105.25% |
| 2005 | 3.11 Billion INR | -15.37% |
| 2004 | 3.68 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 575.68 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 535.85 Billion INR | 0.0% |
| 2023 FY | 535.85 Billion INR | 8.23% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 497.99 Billion INR | 0.0% |
| 2022 Q2 | 473.19 Billion INR | 0.0% |
| 2022 Q4 | 495.1 Billion INR | 6.0% |
| 2022 FY | 495.1 Billion INR | -11.12% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | 467.09 Billion INR | -1.29% |
| 2021 Q4 | 557.02 Billion INR | 0.0% |
| 2021 Q2 | 619.57 Billion INR | 0.0% |
| 2021 FY | 557.02 Billion INR | 40.82% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 FY | 395.57 Billion INR | -6.35% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 330.57 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 395.57 Billion INR | 0.0% |
| 2019 FY | 422.38 Billion INR | -24.61% |
| 2019 Q2 | 358.23 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 422.38 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 417.47 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 560.28 Billion INR | 0.0% |
| 2018 FY | 560.28 Billion INR | 26.86% |
| 2017 Q2 | 335.67 Billion INR | 0.0% |
| 2017 Q3 | 394.55 Billion INR | 17.54% |
| 2017 Q4 | 441.67 Billion INR | 11.94% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 441.67 Billion INR | 45.01% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 304.58 Billion INR | 87.38% |
| 2016 Q4 | 304.58 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 271.36 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 162.54 Billion INR | 122.48% |
| 2015 Q4 | 162.54 Billion INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 62.92 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q4 | 73.06 Billion INR | 0.0% |
| 2014 FY | 73.06 Billion INR | -23.51% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 50.96 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 88.15 Billion INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 95.51 Billion INR | 24.24% |
| 2013 Q4 | 95.51 Billion INR | 0.0% |
| 2012 FY | 76.88 Billion INR | 362.4% |
| 2012 Q4 | 76.88 Billion INR | 0.0% |
| 2012 Q3 | - INR | 0.0% |
| 2012 Q2 | - INR | 0.0% |
| 2011 Q4 | 16.62 Billion INR | 0.0% |
| 2011 FY | 16.62 Billion INR | 119.68% |
| 2010 FY | 7.56 Billion INR | -41.55% |
| 2009 FY | 12.94 Billion INR | -3.29% |
| 2008 FY | 13.39 Billion INR | 86.94% |
| 2007 FY | 7.16 Billion INR | 12.06% |
| 2006 FY | 6.39 Billion INR | 105.25% |
| 2005 FY | 3.11 Billion INR | -15.37% |
| 2004 FY | 3.68 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 1.43 Billion INR | -37359.135% |
| Ind-Swift Limited | 10.13 Billion INR | -5184.631% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -16000.366% |
| Sakar Healthcare Limited | 793.51 Million INR | -67429.741% |
| Aurobindo Pharma Limited | 66.47 Billion INR | -706.091% |
| Innova Captab Limited | 2.45 Billion INR | -21762.528% |
| Divi's Laboratories Limited | 30 Million INR | -1786097.667% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -1165267.535% |
| Morepen Laboratories Limited | 289.99 Million INR | -184684.166% |
| Mankind Pharma Limited | 2.07 Billion INR | -25765.381% |
| Sequent Scientific Limited | 4.87 Billion INR | -10887.636% |
| Wanbury Limited | 1.16 Billion INR | -45902.587% |
| Laurus Labs Limited | 25.77 Billion INR | -1979.069% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -8331.608% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -312390.844% |
| Alembic Limited | 91.5 Million INR | -585538.579% |
| Hikal Limited | 8.17 Billion INR | -6454.212% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -10342.344% |
| Neuland Laboratories Limited | 953.89 Million INR | -56075.862% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -14088.934% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | -4253.288% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -163471.215% |
| Themis Medicare Limited | 957.92 Million INR | -55839.763% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Zydus Lifesciences Limited | 8.04 Billion INR | -6563.259% |
| Lupin Limited | 29.21 Billion INR | -1734.023% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -3100399.335% |
| Wockhardt Limited | 23.56 Billion INR | -2174.445% |
| Vaishali Pharma Limited | 134.91 Million INR | -397074.061% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -18685.602% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -599228.151% |
| Jubilant Pharmova Limited | 36.64 Billion INR | -1362.498% |
| FDC Limited | 205.18 Million INR | -261059.1% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | -2576.62% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -169226.561% |
| Eris Lifesciences Limited | 27.81 Billion INR | -1826.672% |
| Venus Remedies Limited | 413.3 Million INR | -129553.835% |
| ZIM Laboratories Limited | 1.08 Billion INR | -49140.731% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -53571.751% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 19.7 Million INR | -2719997.97% |
| Shilpa Medicare Limited | 9.37 Billion INR | -5616.512% |
| Albert David Limited | 33.24 Million INR | -1611894.814% |
| Ajanta Pharma Limited | 352.8 Million INR | -151787.557% |
| Hester Biosciences Limited | 2.44 Billion INR | -21827.477% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -82344.458% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | -5197.67% |
| Gufic Biosciences Limited | 3.32 Billion INR | -15995.946% |
| Windlas Biotech Limited | 36.41 Million INR | -1471636.611% |
| Procter & Gamble Health Limited | 95.6 Million INR | -560422.28% |
| Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | -170815.426% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -54306.102% |
| Granules India Limited | 13.15 Billion INR | -3974.777% |
| Aarti Drugs Limited | 5.64 Billion INR | -9396.505% |
| Bal Pharma Limited | 1.39 Billion INR | -38272.033% |
| Alkem Laboratories Limited | 14.18 Billion INR | -3677.887% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | -1536.876% |
| Lincoln Pharmaceuticals Limited | 10.66 Million INR | -5022953.056% |
| Medicamen Biotech Limited | 308.17 Million INR | -173783.189% |
| Unichem Laboratories Limited | 2.47 Billion INR | -21549.639% |
| Bafna Pharmaceuticals Limited | 243.89 Million INR | -219610.816% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -12209043.313% |
| Valiant Laboratories Limited | 767.08 Million INR | -69756.665% |
| Orchid Pharma Limited | 1.35 Billion INR | -39540.252% |
| Medico Remedies Limited | 80.5 Million INR | -665530.652% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -322287.315% |
| Ipca Laboratories Limited | 14.38 Billion INR | -3625.488% |
| Brooks Laboratories Limited | 56.41 Million INR | -949685.179% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -73825.291% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | -1232.32% |
| NATCO Pharma Limited | 3.71 Billion INR | -14335.865% |
| Suven Life Sciences Limited | 7.09 Million INR | -7550404.438% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -27603.08% |
| Strides Pharma Science Limited | 25.16 Billion INR | -2029.074% |
| Indoco Remedies Limited | 6.71 Billion INR | -7874.571% |
| Alpa Laboratories Limited | 52.46 Million INR | -1021265.291% |
| Lasa Supergenerics Limited | 220.76 Million INR | -242631.675% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -87530.303% |